Daunorubicin and gambogic acid coloaded cysteamine-CdTe quantum dots minimizing the multidrug resistance of lymphoma in vitro and in vivo

To minimize the side effects and the multidrug resistance (MDR) arising from daunorubicin (DNR) treatment of malignant lymphoma, a chemotherapy formulation of cysteamine-modified cadmium tellurium (Cys-CdTe) quantum dots coloaded with DNR and gambogic acid (GA) nanoparticles (DNR-GA-Cys-CdTe NPs) wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yi, Wang, Ruju, Chen, Bing, Sun, Dan, Hu, Yong, Xu, Peipei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077128/
https://www.ncbi.nlm.nih.gov/pubmed/27799767
http://dx.doi.org/10.2147/IJN.S115037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077128/
https://www.ncbi.nlm.nih.gov/pubmed/27799767
http://dx.doi.org/10.2147/IJN.S115037

Ejemplares similares